Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients Under General Anesthesia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Obstructive Pulmonary Disease
- Sponsor
- Employee's State Insurance Corporation, New Delhi
- Enrollment
- 45
- Primary Endpoint
- Estimation of Volume consumption of Sevoflurane
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be studied in accordance with age, sex, duration , type of surgery, site of surgery and BMI.The volume consumption of sevoflurane is compared with Chronic Obstructive Pulmonary Disease and Normal Patients .
Detailed Description
Chronic Obstructive pulmonary disease is known to escalate the consumption of Inhalation Agents in General Anesthesia. Hence the Data to Collect the Official Record
Investigators
Santhosh Kumar T N
Nursing Orderly
Employee's State Insurance Corporation, New Delhi
Eligibility Criteria
Inclusion Criteria
- •Both Sex All Age Group Patient willing to give consent COPD patient
Exclusion Criteria
- •Not willing to give consent Cancerous Lung Lung Lobectomy
Outcomes
Primary Outcomes
Estimation of Volume consumption of Sevoflurane
Time Frame: 8 weeks
The consumption is expressed in Volume ml/kg